{name}
{subtitle}
A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)
city
~4 mi. (Woolloongabba, Australia, +89 more cities)
facility
Princess Alexandra Hospital
biomarker
ER Positive, +1 more biomarker
drug
giredestrant, +1 more drug
A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer
city
~4 mi. (Woolloongabba, Australia, +192 more cities)
facility
Princess Alexandra Hospital
biomarker
ER Positive, +1 more biomarker
drug
abemaciclib, +1 more drug
drug type
hormone therapy, +1 more type
A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer
city
~4 mi. (Woolloongabba, Australia, +383 more cities)
facility
Princess Alexandra Hospital; Cancer Trials Unit
biomarker
ER Negative, +2 more biomarkers
drug
atezolizumab, +4 more drugs
drug type
chemotherapy, +1 more type
Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)
city
~4 mi. (Brisbane, Australia, +140 more cities)
facility
Princess Alexandra Hospital ( Site 0006)
drug
lenvatinib, +2 more drugs
drug type
chemotherapy, +2 more types
Investigation of Radium-223 Dichloride (Xofigo), a Treatment That Gives Off Radiation That Helps Kill Cancer Cells, Compared to a Treatment That Inactivates Hormones (New Antihormonal Therapy, NAH) in Patients With Prostate Cancer That Has Spread to the Bone Getting Worse on or After Earlier NAH
city
~4 mi. (Brisbane, Australia, +122 more cities)
facility
Icon Cancer Care
Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)
city
~4 mi. (Woolloongabba, Australia, +199 more cities)
facility
Princess Alexandra Hospital ( Site 0228)
A Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate Cancer
city
~4 mi. (Woolloongabba, Australia, +271 more cities)
facility
Princess Alexandra Hospital
drug
docetaxel, +2 more drugs
drug type
chemotherapy, +2 more types
A Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (persevERA Breast Cancer)
city
~4 mi. (Woolloongabba, Australia, +262 more cities)
facility
Princess Alexandra Hospital; Division of Cancer Services
biomarker
ER Positive, +1 more biomarker
drug
giredestrant, +2 more drugs
drug type
hormone therapy, +1 more type
A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
city
~4 mi. (Woolloongabba, Australia, +260 more cities)
facility
Princess Alexandra Hospital; Cancer Trials Unit
biomarker
ERBB2 Amplification, +1 more biomarker
drug type
immunotherapy, +1 more type